查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1455670

利拉鲁肽市场，按应用、分布、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Liraglutide Market, By Application, By Distribution, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年利拉鲁肽市场规模为89.8234亿美元，2024年至2032年复合CAGR为11.34%。

利拉鲁肽市场-市场动态

提高对肥胖和久坐生活方式的认识，以推动市场需求

由于肥胖率和久坐生活方式的不断上升，导致糖尿病人口随着时间的推移逐渐增加，预计该市场的利拉鲁肽将显着增长。此外，不正确的饮食习惯和糖尿病的潜在盛行率也导致了这一趋势。此外，研发投资的增加，加上技术的进步和新产品的推出，为预测期内 GLP-1 激动剂的市场扩张提供了良好的机会。

利拉鲁肽市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 11.34% 左右的CAGR成长

根据配销通路细分，预计零售药局和药局将在 2023 年呈现最大市场份额

根据应用细分，糖尿病治疗是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

利拉鲁肽市场-細項分析：

全球利拉鲁肽市场根据应用、分布和地区进行细分。

根据配销通路，市场分为三类：医院药房、零售药房和药房以及网路药房。到 2023 年，主要的配销通路是零售药房和药房。该管道为寻求利拉鲁肽的患者提供了便利和可及性，使其成为获得药物的热门选择。虽然医院药局可能发挥重要作用，特别是对于在医院环境中接受治疗的患者而言，但零售药局和药局提供的更广泛的可及性通常会带来更高的销售和市场渗透率。网路药局也可能有助于分销，特别是对于喜欢在网路上订购和送货便利的患者。然而，零售药局和药局通常拥有更成熟的存在，因此可能占据更大的市场份额。

根据应用市场分为两类：糖尿病治疗和体重管理。在利拉鲁肽市场中，糖尿病治疗将在2023 年占据显着地位。利拉鲁肽是一种主要用于治疗2 型糖尿病的药物，作为胰高血糖素样肽-1 (GLP-1)受体激动剂，透过以下方式有效调节血糖值：刺激胰岛素分泌，抑制升糖素释放，延缓胃排空。利拉鲁肽在血糖控制方面的有效性，加上减轻体重和降低心血管风险等辅助性益处，使利拉鲁肽成为糖尿病管理的基石疗法。因此，糖尿病治疗领域受到医疗保健提供者和患者的巨大需求，努力实现血糖目标并有效降低糖尿病相关併发症的风险。

利拉鲁肽市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

利拉鲁肽市场-竞争格局：

在利拉鲁肽市场，该公司正在部署各种策略来满足不断增长的需求并改善患者的治疗效果。这些策略包括正在进行的研究和开发计划，旨在完善利拉鲁肽的配方和递送方法，以提高其有效性并改善患者便利性。此外，该公司正在分配资源进行临床试验，以研究利拉鲁肽的新适应症，例如在降低心血管风险和治疗非酒精性脂肪肝方面的潜在作用。此外，行销工作的重点是提高医疗保健专业人员和患者的认识，旨在促进更广泛的采用和市场渗透。

最近的发展：

2023 年10 月，全球生物製药公司Biocon 宣布与总部位于加拿大的专业製药公司Juno Pharmaceuticals 合作，将利拉鲁肽商业化，这是一种药物设备组合，旨在治疗和管理2 型糖尿病和肥胖症。加拿大市场。根据协议条款，Biocon 将负责获得 Liraglutide 的政府批准，并随后监督其在加拿大各地的生产和分销。

目录

第一章：利拉鲁肽市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 利拉鲁肽市场片段（按应用）
    • 利拉鲁肽市场片段（依分布）
    • 利拉鲁肽市场片段（按国家/地区）
    • 按地区分類的利拉鲁肽市场片段
  • 竞争洞察

第 3 章：利拉鲁肽主要市场趋势

  • 利拉鲁肽市场驱动因素
    • 市场驱动因素的影响分析
  • 利拉鲁肽市场限制
    • 市场限制影响分析
  • 利拉鲁肽市场机会
  • 利拉鲁肽市场未来趋势

第 4 章：利拉鲁肽产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：利拉鲁肽市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：利拉鲁肽市场格局

  • 2023 年利拉鲁肽市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：利拉鲁肽市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 糖尿病治疗
    • 体重管理

第 8 章：利拉鲁肽市场 - 按分布

  • 概述
    • 按分布分類的细分市场占有率分析
    • 医院药房
    • 零售药局和药局
    • 网路药局

第 9 章：利拉鲁肽市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 利拉鲁肽北美主要生产商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按分布）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 利拉鲁肽欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按分布）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 利拉鲁肽亚太地区主要生产商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（按分布）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 利拉鲁肽拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按分布）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 利拉鲁肽中东和非洲主要生产商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按分布）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析-利拉鲁肽产业

  • 竞争仪表板
  • 公司简介
    • Bachem
    • HEC Pharm
    • Kingpep Biotechnology
    • Shenzhen JYMed Technology
    • Novo Nordisk
    • Eli Lilly and Company
    • Boehringer Ingelheim
    • AstraZeneca
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2333

REPORT HIGHLIGHT

Liraglutide Market size was valued at USD 8,982.34 Million in 2023, expanding at a CAGR of 11.34% from 2024 to 2032.

Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, serves as a treatment for type-2 diabetes and chronic obesity. It becomes necessary when diet and exercise alone fail to adequately control blood sugar levels. Typically employed as a second-line therapy for diabetes, following initial treatment with metformin, liraglutide is also utilized to mitigate the risk of heart and blood vessel complications, including heart attacks and strokes, in individuals with type-2 diabetes and pre-existing heart or blood vessel conditions. Marketed under the brand names Victoza and Saxenda, liraglutide addresses critical health concerns in diabetic and obese populations.

Liraglutide Market- Market Dynamics

Increasing awareness rates of obesity and sedentary lifestyles, to propel market demand

The Liraglutide for this market is expected to witness significant growth driven by escalating rates of obesity and sedentary lifestyles, which have led to a gradual increase in the diabetic population over time. Additionally, improper dietary habits and the underlying prevalence of diabetes disorders contribute to this trend. Furthermore, increased investment in research and development, coupled with technological advancements and the introduction of new products, present promising opportunities for the expansion of GLP-1 agonists in the market over the forecast period.

Liraglutide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.34% over the forecast period (2024-2032)

Based on distribution channel segmentation, retail pharmacies and drug stores was predicted to show maximum market share in the year 2023

Based on application segmentation, Diabetes Treatment was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Liraglutide Market- Segmentation Analysis:

The Global Liraglutide Market is segmented on the basis of Application, Distribution, and Region.

The market is divided into three categories based on distribution channel: Hospital Pharmacies, Retail Pharmacies & Drug Stores and Online Pharmacies. The dominant distribution channel is retail pharmacies and drug stores in 2023. This channel offers convenience and accessibility to patients seeking liraglutide, making it a popular choice for obtaining medications. While hospital pharmacies may play a significant role, especially for patients receiving treatment within hospital settings, the broader accessibility provided by retail pharmacies and drug stores often results in higher sales volume and market penetration. Online pharmacies may also contribute to distribution, particularly for patients preferring the convenience of online ordering and delivery. However, retail pharmacies and drug stores typically have a more established presence and may therefore hold a larger share of the market.

The market is divided into two categories based on application: Diabetes Treatment and Weight Management. Within the liraglutide market, the diabetes treatment holds a notable position in 2023. Liraglutide, a medication predominantly prescribed for managing type 2 diabetes, functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, effectively regulating blood sugar levels by stimulating insulin secretion, suppressing glucagon release, and delaying gastric emptying. Its effectiveness in glycemic control, combined with ancillary benefits such as weight reduction and mitigating cardiovascular risks, establishes liraglutide as a cornerstone therapy for diabetes management. As a result, the diabetes treatment segment experiences substantial demand from healthcare providers and patients striving to attain glycemic targets and mitigate the risk of diabetes-related complications effectively.

Liraglutide Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Liraglutide Market- Competitive Landscape:

In the Liraglutide market, companies are deploying varied strategies to address increasing demand and enhance patient outcomes. These strategies encompass ongoing research and development initiatives aimed at refining the formulation and delivery methods of liraglutide, with the goal of enhancing its effectiveness and improving patient convenience. Moreover, companies are allocating resources to conduct clinical trials to investigate new indications for liraglutide, such as its potential role in reducing cardiovascular risks and treating non-alcoholic fatty liver disease. Additionally, marketing efforts are focused on raising awareness among healthcare professionals and patients alike, aiming to foster broader adoption and market penetration.

Recent Developments:

In October 2023, Biocon, a global biopharmaceutical company, unveiled a collaboration with Juno Pharmaceuticals, a specialty pharmaceutical company headquartered in Canada, to commercialize Liraglutide, a drug-device combination designed for the treatment and management of type-2 diabetes and obesity within the Canadian market. Per the terms of the agreement, Biocon will undertake the responsibility of obtaining government approvals for Liraglutide and subsequently oversee its manufacturing and distribution throughout Canada.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIRAGLUTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Bachem

HEC Pharm

Kingpep Biotechnology

Shenzhen JYMed Technology

Novo Nordisk

Eli Lilly and Company

Boehringer Ingelheim

AstraZeneca

Others

GLOBAL LIRAGLUTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Diabetes Treatment
  • Weight Management

GLOBAL LIRAGLUTIDE MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

GLOBAL LIRAGLUTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Liraglutide Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Liraglutide Market Snippet by Application
    • 2.1.2.Liraglutide Market Snippet by Distribution
    • 2.1.3.Liraglutide Market Snippet by Country
    • 2.1.4.Liraglutide Market Snippet by Region
  • 2.2.Competitive Insights

3.Liraglutide Key Market Trends

  • 3.1.Liraglutide Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Liraglutide Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Liraglutide Market Opportunities
  • 3.4.Liraglutide Market Future Trends

4.Liraglutide Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Liraglutide Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Liraglutide Market Landscape

  • 6.1.Liraglutide Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Liraglutide Market - By Application

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 7.1.2.Diabetes Treatment
    • 7.1.3.Weight Management

8.Liraglutide Market - By Distribution

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 8.1.2.Hospital Pharmacies
    • 8.1.3.Retail Pharmacies & Drug Stores
    • 8.1.4.Online Pharmacies

9.Liraglutide Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Liraglutide Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Liraglutide Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Liraglutide Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Liraglutide Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Liraglutide Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Liraglutide Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bachem
    • 10.2.2.HEC Pharm
    • 10.2.3.Kingpep Biotechnology
    • 10.2.4.Shenzhen JYMed Technology
    • 10.2.5.Novo Nordisk
    • 10.2.6.Eli Lilly and Company
    • 10.2.7.Boehringer Ingelheim
    • 10.2.8.AstraZeneca
    • 10.2.9.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liraglutide Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Liraglutide Market, by Application 2019-2032 (USD Million)
  • TABLE Liraglutide Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Liraglutide Market, by Distribution 2019-2032 (USD Million)
  • TABLE Liraglutide Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liraglutide Market, by Region 2019-2032 (USD Million)
  • TABLE North America Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Liraglutide Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liraglutide Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liraglutide Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liraglutide Market, by Distribution, 2019-2032 (USD Million)